STING1 and neoplasm: Compared to the control group, the expression of STING and TBK1 was higher (Figure S3C), and the tumor volume in the LAMP2A-deficient group was smaller with longer survival times, which was consistent with the results from in vitro experiments (Figure 5E, F).